For specialists
Story
PATENT No. 2021812 RECEIVED FOR “MEANS FOR TREATMENT OF ARTHROLOGICAL DISEASES” FOR “MUKOSAT”
PATENT No. 2612019 “METHOD FOR PRODUCING INJECTION FORM OF THE DRUG BASED ON CHONDROITIN SULPHATE” IS RECEIVED. PRIORITY DATE: 12/11/2015
PATENT No. 2612014 “MEANS FOR TREATMENT OF ARTHROLOGICAL DISEASES” IS RECEIVED. PRIORITY DATE: 10/19/2015
A CERTIFICATE IS RECEIVED FOR TK “MUKOSAT” No. 2612014 DATE OF REGISTRATION OF THE AGREEMENT OF REMOVAL OF RIGHTS FROM “GILSINP” IN FAVOR OF LLC “DIAMED-PHARMA”: 05.10.2015
CERTIFICATE IS RE
CHANGE OF REGISTRATION CERTIFICATE HOLDER P N000570 / 01 IN FAVOR OF DIAMED-PHARMA LLC
Features of the drug
- ORIGINAL DEVELOPMENT
- PATENTED MANUFACTURING TECHNOLOGY
- HIGH SAFETY PROFILE
DUE TO THE ABSENCE OF TOXIC EXCIPIENTS
Instructions for use





RELEASE FORM
AMPOULES WITH A SOLUTION FOR V / M ADMINISTRATION OF 1 ML OR 2 ML (100 MG / ML)

INDICATIONS FOR USE
DEGENERATIVE DISEASES OF THE JOINTS AND SPINE:
- OSTEOARTHROSIS OF THE SPINE
- OSTEOARTHROSIS OF THE SPINE

DOSAGE AND ADMINISTRATION
1 ml First 3 injections, every other day
2 ml C 4 injections until the end of the course, every other day
25-30 injection Recommended course of therapy
after 6 months If necessary, repetition is possible